OpenVSafe by OpenVAERS
Search V-safe

HQE-25254-23067

2 vaccinations 1 coded response 11 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
770 / TX
Registered
2021-01-13
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-12
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-13
    Registered in v-safe
  3. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-01-13
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-03
    Dose 2 — Pfizer-BioNTech
  8. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Nausea
    Adult check-in
  10. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  11. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-03-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-08-04
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-02-03
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Fatigue, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Fatigue, pregnancy, covid infection
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-12Pfizer-BioNTech
22021-02-03Pfizer-BioNTech

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 11 — 12 months, dose 2

2022-02-03

Symptoms: Fatigue, pregnancy, covid infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDFatigue · · ✓
SDPregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release